NCT05749367

Brief Summary

Postoperative pain in hip fractures is challenging and requires adequate management. Peripheral nerve blocks are already known as superior than systemic analgesia in this scenario, but the best analgesic regional technique is still unknown. The investigators propose a study to compare the postoperative analgesia of hip fractures between pericapsular nerve group block plus lateral femoral cutaneous nerve block and suprainguinal fascia iliaca block

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

March 6, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2023

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

February 8, 2023

Last Update Submit

February 27, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Dynamic Post-op Hip Pain

    To assess dynamic hip pain (passive leg elevation at 15°) in postoperative period using the Numeric Rating Scale (0-10), on which patients rate their current pain intensity from (no pain) to 10 (worst possible pain).

    6 hours after spinal anesthesia.

  • Dynamic Post-op Hip Pain

    To assess dynamic hip pain (passive leg elevation at 15°) in postoperative period using the Numeric Rating Scale (0-10), on which patients rate their current pain intensity from (no pain) to 10 (worst possible pain).

    12 hours after spinal anesthesia

  • Dynamic Post-op Hip Pain

    To assess dynamic hip pain (passive leg elevation at 15°) in postoperative period using the Numeric Rating Scale (0-10), on which patients rate their current pain intensity from (no pain) to 10 (worst possible pain).

    24 hours after spinal anesthesia

Secondary Outcomes (8)

  • Post-op Hip Pain at Rest

    6 hours, 12 hours and 24 hours after spinal anesthesia.

  • Quadriceps muscle strength measured by dynamometry in newton (N).

    6 hours, 12 hours and 24 hours after spinal anesthesia.

  • Quadriceps muscle strength index

    6 hours, 12 hours and 24 hours after spinal anesthesia.

  • Total intravenous morphine dose in milligram over 24 hours

    24 hours

  • Time of the first morphine order in minutes

    24 hours

  • +3 more secondary outcomes

Study Arms (2)

Suprainguinal Fascia Iliaca Block Group

ACTIVE COMPARATOR

Patients will undergo SIFIB with ropivacaine and PENG plus LFCNB with saline solution.

Drug: Ropivacaine + saline solution

PENG Block + Lateral Femoral Cutaneous Nerve Block Group

EXPERIMENTAL

Patients will undergo SIFIB with saline solution and PENG plus LFCNB ropivacaine.

Drug: Saline solution + Ropivacaine

Interventions

SIFIB with 30 ml of 0.5% ropivacaine and PENG Block plus LFCNB with 20 ml and 10 ml of saline solution, respectively.

Also known as: Naropin + saline solution
Suprainguinal Fascia Iliaca Block Group

SIFIB with 30 ml of saline solution and PENG Block plus LFCNB with 20 ml and 10 ml of 0,5% ropivacaine, respectively.

Also known as: Saline solution + Naropin
PENG Block + Lateral Femoral Cutaneous Nerve Block Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with hip fractures who will undergo surgical treatment.
  • Adults over 18 years.
  • American Society of Anesthesiology physical status 1 to 3.
  • Body mass index (BMI) \< 35 Kg/m2.

You may not qualify if:

  • Local anesthetic allergy
  • Coagulopathy
  • American Society of Anesthesiology physical status ≥ 4,
  • Dementia
  • Peripheral polyneuropathy
  • Pregnancy
  • Chronic opioid use (\> 3 months)
  • BMI \>35 Kg/m2
  • Stroke with lower limb motor sequelae
  • Patient refusal/withdrawal
  • Those whose spinal anesthesia has been changed to general anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Odilon Behrens

Belo Horizonte, Minas Gerais, 31.110-430, Brazil

Location

Related Publications (9)

  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.

    PMID: 30063657BACKGROUND
  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

    PMID: 33238043BACKGROUND
  • Bugada D, Bellini V, Lorini LF, Mariano ER. Update on Selective Regional Analgesia for Hip Surgery Patients. Anesthesiol Clin. 2018 Sep;36(3):403-415. doi: 10.1016/j.anclin.2018.04.001. Epub 2018 Jul 11.

    PMID: 30092937BACKGROUND
  • Vermeylen K, Desmet M, Leunen I, Soetens F, Neyrinck A, Carens D, Caerts B, Seynaeve P, Hadzic A, Van de Velde M. Supra-inguinal injection for fascia iliaca compartment block results in more consistent spread towards the lumbar plexus than an infra-inguinal injection: a volunteer study. Reg Anesth Pain Med. 2019 Feb 22:rapm-2018-100092. doi: 10.1136/rapm-2018-100092. Online ahead of print.

    PMID: 30798268BACKGROUND
  • Desmet M, Vermeylen K, Van Herreweghe I, Carlier L, Soetens F, Lambrecht S, Croes K, Pottel H, Van de Velde M. A Longitudinal Supra-Inguinal Fascia Iliaca Compartment Block Reduces Morphine Consumption After Total Hip Arthroplasty. Reg Anesth Pain Med. 2017 May/Jun;42(3):327-333. doi: 10.1097/AAP.0000000000000543.

    PMID: 28059869BACKGROUND
  • Morrison C, Brown B, Lin DY, Jaarsma R, Kroon H. Analgesia and anesthesia using the pericapsular nerve group block in hip surgery and hip fracture: a scoping review. Reg Anesth Pain Med. 2021 Feb;46(2):169-175. doi: 10.1136/rapm-2020-101826. Epub 2020 Oct 27.

    PMID: 33109730BACKGROUND
  • Aliste J, Layera S, Bravo D, Jara A, Munoz G, Barrientos C, Wulf R, Branez J, Finlayson RJ, Tran Q. Randomized comparison between pericapsular nerve group (PENG) block and suprainguinal fascia iliaca block for total hip arthroplasty. Reg Anesth Pain Med. 2021 Oct;46(10):874-878. doi: 10.1136/rapm-2021-102997. Epub 2021 Jul 20.

    PMID: 34290085BACKGROUND
  • Lin DY, Morrison C, Brown B, Saies AA, Pawar R, Vermeulen M, Anderson SR, Lee TS, Doornberg J, Kroon HM, Jaarsma RL. Pericapsular nerve group (PENG) block provides improved short-term analgesia compared with the femoral nerve block in hip fracture surgery: a single-center double-blinded randomized comparative trial. Reg Anesth Pain Med. 2021 May;46(5):398-403. doi: 10.1136/rapm-2020-102315. Epub 2021 Feb 26.

    PMID: 33637625BACKGROUND
  • Macedo MC, Souza MA, Ferreira KR, Campos LO, Souza ISO, Barbosa MA, Brito CJ, Intelangelo L, Barbosa AC. Validity and Test-Retest Reliability of a Novel Push Low-Cost Hand-Held Dynamometer for Knee Strength Assessment during Different Force Ranges. Diagnostics (Basel). 2022 Jan 13;12(1):186. doi: 10.3390/diagnostics12010186.

    PMID: 35054353BACKGROUND

MeSH Terms

Interventions

RopivacaineSaline Solution

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Leonardo SG Oliveira, MD

    Hospital Municipal Odilon Behrens - Belo Horizonte/Brazil and Universidade Federal de Minas Gerais

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leonardo SG Oliveira, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
In the control group, patients will undergo SIFIB with ropivacaine and to maintain the masking they will also undergo PENG and LFCNB with saline solution (sham block). In the experimental group, patients will receive ropivacaine in the PENG block associated with LFCNB and saline solution in the SIFIB. All the work of randomization, editing of the spreadsheet, manipulation of the envelopes, as well as the confidential tabulation of the data during collection will be done by an assistant who will not participate in the anesthesia or data collection. The opening of the envelopes and the preparation of the material for anesthesia will also be done by an assistant who will not participate in the evaluation of the outcomes. The researcher will perform all the procedures and data collection and will not know which group the participant belongs to. The patient will also not know in which group he or she is allocated.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, controlled, randomized and double blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery Department at Medical School of Universidade Federal de Minas Gerais. Ph.D

Study Record Dates

First Submitted

February 8, 2023

First Posted

March 1, 2023

Study Start

March 6, 2023

Primary Completion

October 10, 2023

Study Completion

October 10, 2023

Last Updated

March 1, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations